Sufugolix
Sufugolix (TAK-013) is an orally bioavailable, potent antagonist of the gonadotropin-releasing hormone (GnRH) receptor. It is utilized in preclinical research to investigate hormone-dependent conditions, with studies demonstrating its activity in both in vitro assays and in vivo models for potential therapeutic applications.
Product Specifications
CAS Number
308831-61-0
Product Name Alternative
Inhibitor, human LHRH, monkey LHRH, inhibit, TAK 013, TAK013, TAK-013, Sufugolix
Field of Research
Metabolism Research, Pharmacology & Drug Discovery
Purity
95.06% (May vary between batches)
Solubility
DMSO:25 mg/mL (37.44 mM)
Smiles
CONC (=O) Nc1ccc (cc1) -c1sc2n (Cc3c (F) cccc3F) c (=O) n (-c3ccccc3) c (=O) c2c1CN (C) Cc1ccccc1
Molecular Formula
C36H31F2N5O4S
Molecular Weight
667.72
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GC1732-5mg 5 mg
1,6-Anhydro-3,4-O-isopropylidene-2-O- (2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl) -β-D-galactopyranose
Sign In for Pricing
View Details 
